Young adults and women face steeper addiction challenges, data reveals

This groundbreaking study analyzed over 3,000 individuals across multiple substance use treatment programs to understand how age and sex influence addiction severity, mental health complications, and impulsive behavior. Researchers found that psychiatric comorbidity is extremely common—affecting 61-81% of patients—and is particularly prevalent among those with cannabis or illicit drug use disorders. The data reveals clear patterns: young adults (17-25 years) report significantly higher cannabis and other drug use, greater psychiatric symptoms, increased comorbidity, and elevated impulsivity compared to older patients, despite showing lower motivation to change their behavior.

The gender differences were equally striking: females reported higher rates of anxiety, depression, and PTSD symptoms, greater overall psychiatric comorbidity, and higher "negative urgency"—a measure of impulsive decision-making in response to distressing emotions. Notably, these differences were consistent across age groups, with no interactions between age and sex effects. This suggests that young females with cannabis use disorders face a particularly challenging clinical picture combining high drug use, severe psychiatric symptoms, and impulsive tendencies.

These findings have substantial implications for treatment planning and resource allocation. The research provides critical benchmarks for recognizing that younger patients require integrated approaches addressing not just substance use, but also high psychiatric comorbidity and impulsivity, while female patients specifically need attention to mood and trauma-related symptoms. This high-resolution clinical profile suggests current treatment services may not adequately match the distinct needs of these populations, particularly young adults with cannabis use disorders who show lower motivation to change despite experiencing severe psychiatric complications.